Why Mobile Nurse Visits Have A Place In Clinical Trials, According To Industry Survey

By Miranda McLaren

In the first article of this two-part series, we explore recent survey findings to uncover the impact of mobile visits in clinical trials.

As clinical research evolves, sponsors are increasingly seeking ways to bring studies closer to local communities and potential participants. By reducing barriers for both patients and their support networks, these efforts aim to achieve broader and more diverse enrollment, ultimately enhancing the quality of data required for drug approvals.

Recognizing that traditional site-centric models can place undue burdens on participants, the industry is shifting toward more participant-friendly options, such as mobile visits conducted at patients’ homes or other convenient locations. These community-based models are typically supported by Good Clinical Practice (GCP)-trained registered nurses, who carry out protocol activities like drug administration and follow-up care in mobile settings.

In 2024, GlobalData partnered with PCM Trials, a leader in community-based research, to examine the role of mobile nurse visits in clinical trials. Through a survey of 100 industry professionals with experience in mobile research, we identified the key benefits and challenges of implementing mobile visits, as well as the patient populations most likely to benefit from this model. This article draws on these survey findings and expert interviews to shed light on how mobile visits are shaping the future of clinical trials.